The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
Last week, the Food and Drug Administration banned Red Dye No. 3 over cancer risks. Good.
The FDA approved Vertex Pharmaceuticals’ Journavx, a new non-opioid pain pill for short-term pain. While safer than opioids, ...
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...
Robert F. Kennedy Jr. â€˜s bid to be the nation’s top health official is uncertain after a key Republican joined Democrats to ...